Healthcare

Well over 2,000 major players in the global healthcare sector are profiled in the following pages. From market leaders to niche companies, each business is forensically examined providing all the competitive intelligence you require. Companies covered include pharmaceuticals, biopharmaceuticals, biomedical operations, healthcare service providers, hospital management and supply companies, medical device and technology providers, and much more. The healthcare industry is as close to recession-proof as you can get, stay one step ahead in this incredibly competitive and innovative market with the inside track on competitors, suppliers and potential partners. Healthcare is also a prime area for financial investment; inform your choices with these expert reports from seasoned industry observers. Show Less ... more

• Progen Pharmaceuticals Limited-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Progen Pharmaceuticals Limited-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Del Global Technologies Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Del Global Technologies Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• HealthCor Holdings, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  HealthCor Holdings, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• CryoCor, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  CryoCor, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Enzon Pharmaceuticals Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Enzon Pharmaceuticals Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• LAM Pharmaceutical Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  LAM Pharmaceutical Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Maxygen Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Maxygen Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Micrus Endovascular Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Micrus Endovascular Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Dynatronics Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Dynatronics Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Flamel Technologies SA-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Flamel Technologies SA-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• II-VI Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  II-VI Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Iomai Corporation-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Iomai Corporation-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Medifast Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Medifast Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• MultiCell Technologies Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 19
  MultiCell Technologies Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• Protalex Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 11
  Protalex Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Neurobiological Technologies Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Neurobiological Technologies Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• Peplin Limited-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 22
  Peplin Limited-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Polydex Pharmaceuticals Ltd.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 14
  Polydex Pharmaceuticals Ltd.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• Nutra Pharma Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 16
  Nutra Pharma Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...

• CardioDynamics International Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  CardioDynamics International Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Quigley Corp.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 29
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Vyrex Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 12
  Vyrex Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Clarient, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Clarient, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Penwest Pharmaceuticals Co.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Penwest Pharmaceuticals Co.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Reliv International, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Reliv International, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Cellegy Pharmaceuticals Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Cellegy Pharmaceuticals Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Cyberkinetics Neurotechnology Systems Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Cyberkinetics Neurotechnology Systems Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume...

• Somaxon Pharmaceuticals, Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 14
  Somaxon Pharmaceuticals, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• Vical Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 34
  Vical Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Roche Holding AG-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 121
  Roche Holding AG-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...

• CytRx Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 31
  CytRx Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Carrington Laboratories Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Carrington Laboratories Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Chad Therapeutics Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Chad Therapeutics Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Exelixis Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Exelixis Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Modern Medical Modalities Corporation-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Modern Medical Modalities Corporation-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume...

• Kindred Healthcare Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Kindred Healthcare Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Lifepoint Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Lifepoint Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Compare Generiks, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Compare Generiks, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• E-Z-EM Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  E-Z-EM Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Consolidated Health Care-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 19
  Consolidated Health Care-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Embryo Development Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Embryo Development Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• PanBio Ltd.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  PanBio Ltd.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Cubist Pharmaceuticals Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Cubist Pharmaceuticals Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Harvard Bioscience Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Harvard Bioscience Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Infu-tech, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Infu-tech, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Metabasis Therapeutics Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Metabasis Therapeutics Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Orchid Chemicals & Pharmaceuticals Ltd.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Orchid Chemicals & Pharmaceuticals Ltd.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume...

• Genaera Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Genaera Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• HEALTHSOUTH Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  HEALTHSOUTH Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Northwest Biotherapeutics Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 19
  Northwest Biotherapeutics Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...